Blum KA - Search Results

1

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103.

Ujjani CS, Jung SH, Pitcher B, Martin P, Park SI, Blum KA, Smith SM, Czuczman M, Davids MS, Levine E, Lewis LD, Smith SE, Bartlett NL, Leonard JP, Cheson BD. Ujjani CS, et al. Among authors: blum ka. Blood. 2016 Nov 24;128(21):2510-2516. doi: 10.1182/blood-2016-06-718106. Epub 2016 Oct 3. Blood. 2016. PMID: 27697771 Free PMC article. Clinical Trial.

2

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.

Fracasso PM, Blum KA, Tan BR, Fears CL, Bartlett NL, Arquette MA, Clark RS. Fracasso PM, et al. Among authors: blum ka. Cancer. 2002 Nov 15;95(10):2223-9. doi: 10.1002/cncr.10937. Cancer. 2002. PMID: 12412177 Free article. Clinical Trial.

3

Antibodies for the treatment of diffuse large cell lymphoma.

Blum KA, Bartlett NL. Blum KA, et al. Semin Oncol. 2003 Aug;30(4):448-56. doi: 10.1016/s0093-7754(03)00251-3. Semin Oncol. 2003. PMID: 12939713 Review.

4

Adult Burkitt leukemia and lymphoma.

Blum KA, Lozanski G, Byrd JC. Blum KA, et al. Blood. 2004 Nov 15;104(10):3009-20. doi: 10.1182/blood-2004-02-0405. Epub 2004 Jul 20. Blood. 2004. PMID: 15265787 Free article. Review.

5

90Yttrium-ibritumomab tiuxetan: a novel treatment for non-Hodgkin's lymphoma.

Blum KA, Bartlett NL. Blum KA, et al. Expert Opin Biol Ther. 2004 Aug;4(8):1323-31. doi: 10.1517/14712598.4.8.1323. Expert Opin Biol Ther. 2004. PMID: 15268665 Review.

6

Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.

Hoerr AL, Gao F, Hidalgo J, Tiwari D, Blum KA, Mathews V, Adkins DR, Blum W, Devine S, Vij R, Goodnough LT, Dipersio JF, Khoury HJ. Hoerr AL, et al. Among authors: blum ka, blum w. J Clin Oncol. 2004 Nov 15;22(22):4561-6. doi: 10.1200/JCO.2004.05.035. J Clin Oncol. 2004. PMID: 15542807

7

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia.

Byrd JC, Lin TS, Dalton JT, Wu D, Phelps MA, Fischer B, Moran M, Blum KA, Rovin B, Brooker-McEldowney M, Broering S, Schaaf LJ, Johnson AJ, Lucas DM, Heerema NA, Lozanski G, Young DC, Suarez JR, Colevas AD, Grever MR. Byrd JC, et al. Among authors: blum ka. Blood. 2007 Jan 15;109(2):399-404. doi: 10.1182/blood-2006-05-020735. Epub 2006 Sep 26. Blood. 2007. PMID: 17003373 Free PMC article. Clinical Trial.

8

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

Blum KA, Johnson JL, Niedzwiecki D, Piro LD, Saven A, Peterson BA, Byrd JC, Cheson BD; Cancer and Leukemia Group B Study 9153. Blum KA, et al. Cancer. 2006 Dec 15;107(12):2817-25. doi: 10.1002/cncr.22344. Cancer. 2006. PMID: 17120198 Free article. Clinical Trial.

9

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.

Blum KA, Johnson JL, Niedzwiecki D, Canellos GP, Cheson BD, Bartlett NL. Blum KA, et al. Leuk Lymphoma. 2007 Jul;48(7):1313-9. doi: 10.1080/10428190701411458. Leuk Lymphoma. 2007. PMID: 17613759 Clinical Trial.

10

High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma.

Hamadani M, Benson DM Jr, Lin TS, Porcu P, Blum KA, Devine SM. Hamadani M, et al. Among authors: blum ka. Eur J Haematol. 2008 Dec;81(6):425-31. doi: 10.1111/j.1600-0609.2008.01146.x. Epub 2008 Sep 4. Eur J Haematol. 2008. PMID: 18774954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

196 results

Search Page